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Abstract
Brief exposure to passive smoking immediately elevates blood pressure. However, little is known about the association between
exposure to passive smoking and chronic hypertension. We aimed to examine this association in a cross-sectional study, after
controlling multiple potential confounders.
Participants included 32,098 lifetime nonsmokers (7,216 men and 24,882 women) enrolled in the Japan Multi-Institutional
Collaborative Cohort Study. Passive smoking was assessed using a self-administered questionnaire. The single question about
exposure to passive smoking had five response options: “sometimes or almost never,” “almost every day, 2 hours/day or less,”
“almost every day, 2 to 4 hours/day,” “almost every day, 4 to 6 hours/day,” and “almost every day, 6 hours/day or longer.”
Hypertension was defined as any of the following: systolic blood pressure ≥140mmHg, diastolic blood pressure ≥90mmHg, or use
of antihypertensive medication. Multivariate-adjusted odds ratio (OR) and 95% confidence interval (CI) for hypertension were
estimated by exposure level to passive smoking using unconditional logistic regression models.
The multivariate-adjusted OR for hypertension in those exposed almost every day was 1.11 (95% CI: 1.03–1.20) compared with
those exposed sometimes or almost never. The OR for a 1-hour per day increase in exposure was 1.03 (95% CI: 1.01–1.06, Pfor
trend= .006). This association was stronger in men than in women; the ORs were 1.08 (95% CI: 1.01–1.15, Pfor trend= .036) and 1.03
(95% CI: 1.00–1.05, Pfor trend= .055), respectively.
Our findings suggest importance of tobacco smoke control for preventing hypertension.
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1. Introduction
Hypertension is a strong risk factor for cardiovascular disease,
which is considered one of the greatest public health concerns
worldwide.[1,2] Some previous studies have demonstrated that
exposure to passive smoking elevates blood pressure for a short
period, up to 24hours.[3–5] This can be partially explained by
several biological effects caused by exposure to passive smoking,
such as vasoconstriction mediated by nicotine-induced catechol-
amine release, endothelial dysfunction, and decreased nitric oxide
production.[5–8] Growing evidence has shown that passive
smoking is associated with morbidity and mortality from
cardiovascular diseases,[9–11] suggesting that individuals should
avoid exposure to passive smoking to prevent cardiovascular
disease. These findings imply that daily exposure to passive
smoking might be associated with the incidence of hypertension.
To the best of our knowledge, however, little is known about the
association between exposure to passive smoking and hyperten-
sion among lifetime nonsmokers. To date, we know of seven
epidemiological studies that have succeeded in showing positive
associations between exposure to passive smoking and elevated
blood pressure in general adult populations;[12–18] however, the
generalizability of those results was limited by small sample sizes
and/or restricted regions. Therefore, it can be expected that
examining the association between passive smoking and
hypertension among nonsmokers in a large general population
would yield better understanding of this association, which could
help health authorities in decision-making about policies for
health promotion and intervention to prevent hypertension.
The present study aimed to examine whether the exposure level
to passive smoking is associated with the prevalence of
hypertension among nonsmokers, in a cross-sectional analysis
with adjustment for multiple confounders, using data from a
large cohort study in Japan.
2. Methods
2.1. Participants
Participants in the present study were enrolled in the Japan
Multi-Institutional Collaborative Cohort (J-MICC) Study.[19]
The J-MICC Study is a large cohort study in Japan, launched in
2005, to identify interactions between genetic and lifestyle
factors for lifestyle-related diseases, including any cancer. The
details and rationale of the J-MICC Study have been described
elsewhere.[20] Briefly, participants completed a self-administered
questionnaire about lifestyle and medical information and
donated a peripheral blood sample during a health check-up at
the baseline survey. The J-MICC Study included residents in the
community, health check examinees, and patients of a cancer
hospital. All participants in the study provided their written
informed consent. The study protocol was approved by the
Ethics Committees of Nagoya University Graduate School of
Medicine, Aichi Cancer Center, and other institutions partici-
pating in the J-MICC Study.
A total of 92,642 participants were recruited from 14 different
areas throughout Japan between 2004 and 2013 (the dataset used
in the present study was fixed on January 11, 2018). The study
areas included Chiba, Shizuoka-Sakuragaoka, Okazaki, Aichi,
Shizuoka, Daiko, Iga, Takashima, Kyoto, Tokushima, Saga,
Kagoshima, Fukuoka and the Kyusyu and Okinawa Population
Study (KOPS). Of the total participants, we excluded 37,103
from four areas (Chiba, Aichi, Fukuoka, and KOPS) from this
study because there were no available data on exposure to passive
smoking (Fukuoka and KOPS) or measured blood pressure
(Chiba and Aichi). To examine the effect of exposure to passive
smoking on blood pressure by excluding the effect of active
smoking, we limited participants to those with nearly no
experience of active smoking in their lifetime, leaving 33,293
nonsmokers (i.e., those who had smoked less than 365 cigarettes
during their lifetime). We further excluded those with missing
data for exposure to passive smoking, blood pressure, and use of
antihypertensive medication (n=182, 990 and 23, respectively).
Thus, the present study included 32,098 nonsmokers (7,216 men
and 24,882 women) in the final analysis.
2.2. Assessment of blood pressure, exposure level to
passive smoking, and lifestyle factors
We used a self-administered questionnaire that included the
following demographic characteristics and lifestyle factors:
alcohol consumption, smoking status, exposure to passive
smoking, education level, physical activity, psychological stress,
sleeping hours, family and personal medical history, current
medication, and menstruation in women.
Height and weight were directly measured on the day of the
survey; body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters (kg/m2).
Each participant’s blood pressure was measured by a nurse or
trained staff in the health check-up, using a standard mercury
sphygmomanometer or an automated blood pressure mea-
surement monitor, with the patient in a seated position.
Exposure level to passive smoking was assessed using a single
question: “Have you inhaled the smoke of cigarettes from
others (i.e., smokers) at home, in an office, or elsewhere in the
last year?” with the following five response options: “some-
times or almost never,” “almost every day, 2 hours/day or
less,” “almost every day, 2 to 4 hours/day,” “almost every day,
4 to 6 hours/day,” and “almost every day, 6 hours/day or
longer.” For the present analysis, men who answered “almost
every day, 4 to 6 hours/day” and “almost every day, 6 hours/
day or longer” were combined into the group “almost every
day, 4 hours/day or longer” because of the small number of
men who responded “almost every day, 6 hours/day or longer”
(n=55). Physical activity was estimated as metabolic equiva-
lent hours per day according to the frequency and duration of
daily and leisure time activities.[21,22] Ethanol intake (g/day)
was estimated for current drinkers (defined as those who
consumed alcohol at least once a week during the last year),
based on the reported consumption frequency and amount
consumed per one time for six alcoholic beverages (i.e.,
Japanese sake, shochu, shochu-based cocktails, beer, whisky,
and wine).[23]
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2.3. Statistical analyses
Participant characteristics were presented as mean± standard
deviation (SD) for continuous variables and as number and
proportion for categorical variables in each level of exposure to
passive smoking. The differences in the means or proportions
between exposure levels to passive smoking were tested using
analysis of variance or the chi-squared test, respectively.
Hypertension was defined according to any of the following
criteria: systolic blood pressure ≥140mmHg, diastolic blood
pressure ≥90mmHg, or use of antihypertensive medica-
tion.[24,25] Crude, age- and sex-adjusted, and multivariate-
adjusted odds ratios (ORs) and 95% confidence intervals (CIs)
for hypertension were estimated by exposure level to passive
smoking using unconditional logistic regression models. The
multivariate-adjusted model included the following covariates:
age (as a continuous variable), sex (for men and women
combined only), alcohol consumption (never, former, current
drinkers who consumed <23g/day ethanol, current drinkers
who consumed ≥23g/day ethanol), education level (9, 10–15,
≥16 years), BMI (<18.5, 18.5 to <25, ≥25kg/m2), physical
activity (as a continuous variable), psychological stress (not at
all, not much, a little, a lot), sleeping hours (<6, 6 to <8, ≥8
hours), family history of hypertension (yes, no for both father
and mother), medical history of diabetes mellitus (yes, no),
medical history of dyslipidemia (yes, no), menstruation
(premenopausal, perimenopausal, postmenopausal for women
only) and study area (Shizuoka-Sakuragaoka, Okazaki,
Shizuoka, Daiko, Iga, Takashima, Kyoto, Tokushima, Saga,
Kagoshima). Participants with missing data for covariates were
included as additional categories in the analysis. The linear
trend for risk was evaluated using weight proportional to the
exposure level to passive smoking (as a continuous variable for
1 hour). The assigned scores were as follows: 0 for “sometimes
or almost never,” 1 for “almost every day, 2 hours/day or less,”
3 for “almost every day, 2 to 4 hours/day,” 5 for “almost every
day, 4 to 6 hours/day,” and 6 for “almost every day, 6 hours/day
or longer.”
A P value of <.05 was considered statistically significant. All
statistical analyses were performed using SAS 9.4M5, which runs
on SAS University Edition (SAS Institute Inc., Cary, NC).
3. Results
Table 1 presents characteristics of 32,098 study participants
according to exposure levels to passive smoking. Mean age±SD
was 54.9±9.5 years, and the proportion of men was 22.5%.
Current drinkers accounted for 71.4% of men and 37.1% of
women. Participants with higher exposure levels to passive
smoking were significantly more likely to be young, women, less
educated, obese, physically active, stressed, and to have fewer
sleeping hours. The distributions of medical history of dyslipi-
demia and study area were also significantly different among
exposure levels to passive smoking. There were no significant
differences in alcohol consumption, family history of hyperten-
sion, andmedical history of diabetes mellitus among the exposure
levels.
The multivariate-adjusted ORs and 95% CIs for hypertension
according to the presence of exposure to passive smoking are
shown in Table 2. A total of 10,100 participants (2,814 men and
7,286 women, representing 31.5% of the participants analyzed)
had hypertension. Individuals exposed to passive smoking almost
every day had a significantly higher risk of hypertension
compared with those exposed sometimes or almost never; the
multivariate-adjusted OR was 1.11 (95% CI: 1.03–1.20). In the
analysis stratified by sex, the positive association was significant
only for men, although the direction of association was not
different by sex; the OR was 1.21 (95% CI: 1.00–1.46) for men
and 1.09 (95% CI: 0.99–1.18) for women.
Table 3 shows the association between exposure levels to
passive smoking and risk of hypertension. The risk significantly
increased with exposure level to passive smoking; the multivari-
ate-adjusted OR for a 1-hour per day increase in exposure was
1.03 (95% CI: 1.01–1.06, Pfor trend= .006). In particular, those
exposed almost every day, 4 to <6hours per day, had a
significantly increased risk of hypertension; the multivariate-
adjusted OR was 1.26 (95% CI: 1.04–1.54) compared with
participants exposed sometimes or almost never. When the
analysis was stratified by sex, this association persisted and
appeared to be stronger in men than in women; the OR for a 1-
hour per day increase in exposure was 1.08 (95% CI: 1.01–1.15,
Pfor trend= .036) in men and 1.03 (95% CI: 1.00–1.05, Pfor
trend= .055) in women.
4. Discussion
In this large cross-sectional study from Japan, the presence of
exposure to passive smoking was found to be significantly
positively associated with the prevalence of hypertension among
nonsmokers, independently of multiple potential confounders,
including medical history. The OR for hypertension increased
according to exposure level to passive smoking with a significant
linear trend, and the association was stronger in men than in
women.
Studies exploring the effect of passive smoking on hypertension
have been scarce. To the best of our knowledge, seven
epidemiological studies in general adult populations have
demonstrated a positive association with a small sample size
or in restricted regions.[12–18] A previous cross-sectional study in
Japan showed that those exposed to daily passive smoking had
increased systolic blood pressure by approximately 4 mmHg in
the morning;[13] however, it remains unclear whether exposure to
passive smoking is associated with the prevalence of hyperten-
sion. We revealed that individuals exposed to passive smoking
almost every day have an 11% greater risk of hypertension
compared with those exposed only sometimes or almost never,
after controlling for multiple confounders. In addition, the OR
for hypertension increased according to exposure level to passive
smoking with a significant linear trend; the increased risk for a 1-
hour per day increase in exposure was 8% in men and 3% in
women. Only one study has examined the association between
serum cotinine levels and hypertension among never smokers in
an adult population in the United States; cotinine in the body is
the principal metabolite of nicotine containedmainly in cigarettes
and is considered a biomarker for exposure to smoking.[14] In
that study, the result for the highest quartile of serum cotinine
level (≥0.218ng/mL) was consistent with that in our male
participants who were exposed almost every day, 4hours per day
or longer; the multivariate-adjusted OR for hypertension was
1.44 (95% CI: 1.01–2.04) compared with the lowest quartile of
serum cotinine level (0.025ng/mL). Regarding women, a
previous cross-sectional study in China examining the associa-
tion between the husband’s smoking and wife’s hypertension
showed findings consistent with those for women in the present
study; the multivariate-adjusted OR for hypertension in women
was 1.28 (95% CI: 1.27–1.30) for the group in which only the
husband smoked compared with the group in which both the
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husband and wife were nonsmokers.[16] A most recent study in
Korea also has shown that nonsmoking women exposed to
passive smoking every day, 2hours per day or longer showed a
higher prevalence of hypertension; the multivariate-adjusted OR
was 1.50 (95% CI: 1.10–2.04) compared with those without the
exposure.[18] Our findings reinforce the previously reported
evidence for the association between exposure to passive smoking
and hypertension.
It is well known that both active and passive smoking
immediately elevate blood pressure for a short period in
experimental settings.[3–6,26] The link between smoking and
elevated blood pressure appears to be biologically plausible
because nicotine acts as an adrenergic agonist, inducing local or
systemic catecholamine release at the neuroeffector junction or
the release of vasopressin[6]; however, even findings regarding the
chronic effects of active smoking on blood pressure have been
inconclusive.[26,27] In fact, several cross-sectional studies have
failed to provide any evidence for or have demonstrated a
negative association between smoking and blood pressure.[28–31]
Several studies, however, have shown positive associations.[32–34]
Table 1










day, 2 to <4hours
per day
Almost every




per day P value
No. of participants (n, %) 32,098 27,344 (85.2) 2,669 (8.3) 943 (2.9) 576 (1.8) 566 (1.8)
Age (years, mean±SD) 54.9±9.5 55.1±9.6 53.6±9.0 53.9±8.8 54.3±8.7 54.9±8.4 <0.001
Sex (men, n, %) 7,216 (22.5) 6,510 (23.8) 485 (18.2) 103 (10.9) 63 (10.9) 55 (9.7) <0.001
Alcohol consumption (n, %)
Never 17,237 (53.7) 14,613 (53.4) 1,448 (54.3) 514 (54.5) 327 (56.8) 335 (59.2) 0.09
Former 471 (1.5) 406 (1.5) 42 (1.6) 12 (1.3) 6 (1.0) 5 (0.9)
Current, <23 g/day ethanol 11,634 (36.3) 9,994 (36.6) 949 (35.6) 329 (34.9) 189 (32.8) 173 (30.6)
Current, ≥23 g/day ethanol 2,740 (8.5) 2,320 (8.5) 227 (8.5) 88 (9.3) 53 (9.2) 52 (9.2)
Unknown 16 (0.1) 11 (0.0) 3 (0.1) 0 (0.0) 1 (0.2) 1 (0.2)
Education level (years, n, %)
9 3,288 (10.2) 2,727 (10.0) 280 (10.5) 134 (14.2) 69 (12.0) 78 (13.8) <0.001
10–15 22,224 (69.2) 18,590 (68.0) 2,029 (76.0) 726 (77.0) 452 (78.5) 427 (75.4)
≥16 5,806 (18.1) 5,362 (19.6) 290 (10.9) 63 (6.7) 44 (7.6) 47 (8.3)
Unknown 780 (2.4) 665 (2.4) 70 (2.6) 20 (2.1) 11 (1.9) 14 (2.5)
Body mass index (kg/m2, n, %)
<18.5 2,549 (7.9) 2,205 (8.1) 199 (7.5) 62 (6.6) 55 (9.6) 28 (5.0) <0.001
18.5 to <25.0 22,939 (71.5) 19,656 (71.9) 1,855 (69.5) 663 (70.3) 375 (65.1) 390 (68.9)
≥25.0 6,601 (20.6) 5,475 (20.0) 615 (23.0) 218 (23.1) 145 (25.2) 148 (26.2)
Unknown 9 (0.0) 8 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 0 (0.0)
Physical activity (METs hours/day, mean±SD) 15.7±12.0 15.5±11.9 16.6±12.6 16.7±12.8 16.8±12.6 16.3±12.5 <0.001
Psychological stress
Not at all 941 (2.9) 838 (3.1) 60 (2.3) 21 (2.2) 10 (1.7) 12 (2.1) <0.001
Not much 6,023 (18.8) 5,292 (19.4) 418 (15.7) 144 (15.3) 84 (14.6) 85 (15.0)
A little 15,435 (48.1) 13,233 (48.4) 1,240 (46.5) 461 (48.9) 266 (46.2) 235 (41.5)
A lot 8,990 (28.0) 7,375 (27.0) 891 (33.4) 298 (31.6) 207 (35.9) 219 (38.7)
Unknown 709 (2.2) 606 (2.2) 60 (2.3) 19 (2.0) 9 (1.6) 15 (2.7)
Sleeping hours (hours/day, n, %)
<6 4,314 (13.4) 3,568 (13.1) 409 (15.3) 147 (15.6) 97 (16.8) 93 (16.4) <0.001
6 to <8 22,834 (71.1) 19,419 (71.0) 1,937 (72.6) 682 (72.3) 411 (71.4) 385 (68.0)
≥8 4,935 (15.4) 4,347 (15.9) 320 (12.0) 114 (12.1) 68 (11.8) 86 (15.2)
Unknown 15 (0.1) 10 (0.0) 3 (0.1) 0 (0.0) 0 (0.0) 2 (0.4)
Family history of hypertension (n, %)
Father 8,420 (26.2) 7,197 (26.3) 697 (26.1) 234 (24.8) 131 (22.7) 161 (28.5) 0.06
Mother 10,594 (33.0) 9,009 (33.0) 870 (32.6) 330 (35.0) 203 (35.2) 182 (32.2) 0.14
Medical history (n, %)
Diabetes mellitus 1,485 (4.6) 1,267 (4.6) 117 (4.4) 35 (3.7) 38 (6.6) 28 (5.0) 0.12
Dyslipidemia 6,154 (19.2) 5,372 (19.7) 433 (16.2) 146 (15.5) 116 (20.1) 87 (15.4) <0.001
Study area (n, %)
Shizuoka-Sakuragaoka 2,966 (9.2) 2,770 (10.1) 117 (4.4) 34 (3.6) 18 (3.1) 27 (4.8) <0.001
Okazaki 3,542 (11.0) 3,177 (11.6) 217 (8.1) 83 (8.8) 34 (5.9) 31 (5.5)
Shizuoka 2,498 (7.8) 2,164 (7.9) 215 (8.1) 52 (5.5) 29 (5.0) 38 (6.7)
Daiko 3,490 (10.9) 2,928 (10.7) 316 (11.8) 110 (11.7) 80 (13.9) 56 (9.9)
Iga 611 (1.9) 519 (1.9) 54 (2.0) 17 (1.8) 8 (1.4) 13 (2.3)
Takashima 2,401 (7.5) 1,977 (7.2) 224 (8.4) 102 (10.8) 43 (7.5) 55 (9.7)
Kyoto 3,671 (11.4) 3,328 (12.2) 205 (7.7) 69 (7.3) 36 (6.3) 33 (5.8)
Tokushima 717 (2.2) 646 (2.4) 40 (1.5) 9 (1.0) 12 (2.1) 10 (1.8)
Saga 7,263 (22.6) 5,797 (21.2) 838 (31.4) 257 (27.3) 181 (31.4) 190 (33.6)
Kagoshima 4,939 (15.4) 4,038 (14.8) 443 (16.6) 210 (22.3) 135 (23.4) 113 (20.0)
METs=metabolic equivalents, SD= standard deviation.
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In addition, longitudinal studies examining the risk score for
predicting incidence of hypertension have shown that smoking is
significantly associated with onset of hypertension after multi-
variate adjustment[35–37] whereas other studies have shown no
association.[38,39] The reasons for this inconsistency remain
unclear. Nicotine-induced vasoconstriction is responsible for an
acute transient increase in blood pressure,[6] and this state is
followed by decreased blood pressure as a consequence of
nicotine’s depressant effects. In the long term, carbon monoxide
directly plays a role in causing endothelial dysfunction of the
arterial wall[8] and structurally irreversible alterations, such as
arterial stiffness.[40] These changes caused by active and passive
smoking could potentially be associated with a state of
chronically increased blood pressure or hypertension.[41] Further
studies are required to confirm the association of passive smoking
with hypertension in the general population.
Table 2
ORs and 95% CIs for hypertension according to exposure to passive smoking among nonsmokers.
Passive smoking
Sometimes or almost never Almost every day
Men and women (n=32,098)
No. of participants 27,344 4,754
No. of hypertension cases (n, %) 8,586 (31.4) 1,514 (31.9)
Crude OR (95% CI) 1.00 (Ref.) 1.02 (0.96–1.09)
Age- and sex-adjusted OR (95% CI) 1.00 (Ref.) 1.21 (1.13–1.30)
Multivariate-adjusted OR
∗
(95% CI) 1.00 (Ref.) 1.11 (1.03–1.20)
Men (n=7,216)
No. of participants 6,510 706
No. of hypertension cases (n, %) 2,525 (38.8) 289 (40.9)
Crude OR (95% CI) 1.00 (Ref.) 1.09 (0.93–1.28)
Age-adjusted OR (95% CI) 1.00 (Ref.) 1.35 (1.15–1.60)
Multivariate-adjusted OR
∗
(95% CI) 1.00 (Ref.) 1.21 (1.00–1.46)
Women (n=24,882)
No. of participants 20,834 4,048
No. of hypertension cases (n, %) 6,061 (29.1) 1,225 (30.3)
Crude OR (95% CI) 1.00 (Ref.) 1.06 (0.98–1.14)
Age-adjusted OR (95% CI) 1.00 (Ref.) 1.19 (1.10–1.28)
Multivariate-adjusted OR
∗
(95% CI) 1.00 (Ref.) 1.09 (0.99–1.18)
CI= confidence interval, OR=odds ratio.
∗
Adjusted for age (continuous variable), sex (men and women combined only), alcohol consumption, education level, body mass index, physical activity (continuous variable), psychological stress, sleeping hours,
family history of hypertension in father, family history of hypertension in mother, medical history of diabetes mellitus, medical history of dyslipidemia, menstruation status (women only), and study area.
Table 3



















Men and women (n=32,098)
No. of participants 27,344 2,669 943 576 566
No. of hypertension cases (n, %) 8,586 (31.4) 821 (30.8) 300 (31.8) 202 (35.1) 191 (33.8)
Crude OR (95% CI) 1.00 (Ref.) 0.97 (0.89–1.06) 1.02 (0.89–1.17) 1.18 (0.99–1.40) 1.11 (0.93–1.33) 1.02 (0.99–1.04) .069
Age- and sex-adjusted OR (95% CI) 1.00 (Ref.) 1.11 (1.02–1.22) 1.16 (1.00–1.34) 1.31 (1.09–1.57) 1.18 (0.98–1.42) 1.04 (1.02–1.07) <.001
Multivariate-adjusted OR
∗
(95% CI) 1.00 (Ref.) 1.08 (0.98–1.19) 1.14 (0.97–1.33) 1.26 (1.04–1.54) 1.10 (0.90–1.34) 1.03 (1.01–1.06) .006
Men (n=7,216)
No. of participants 6,510 485 103 118†
No. of hypertension cases (n, %) 2,525 (38.8) 188 (38.8) 47 (45.6) 54 (45.8)
Crude OR (95% CI) 1.00 (Ref.) 1.00 (0.83–1.21) 1.33 (0.90–1.96) 1.33 (0.92–1.92) 1.06 (0.99–1.12) .056
Age-adjusted OR (95% CI) 1.00 (Ref.) 1.24 (1.01–1.51) 1.60 (1.06–2.42) 1.70 (1.15–2.48) 1.12 (1.06–1.19) <.001
Multivariate-adjusted OR
∗
(95% CI) 1.00 (Ref.) 1.16 (0.93–1.45) 1.21 (0.76–1.91) 1.43 (0.94–2.20) 1.08 (1.01–1.15) .036
Women (n=24,882)
No. of participants 20,834 2,184 840 513 511
No. of hypertension cases (n, %) 6,061 (29.1) 633 (29.0) 253 (30.1) 174 (33.9) 165 (32.3)
Crude OR (95% CI) 1.00 (Ref.) 1.00 (0.90–1.10) 1.05 (0.90–1.22) 1.25 (1.04–1.51) 1.16 (0.96–1.40) 1.03 (1.01–1.05) .010
Age-adjusted OR (95% CI) 1.00 (Ref.) 1.13 (1.02–1.25) 1.20 (1.03–1.41) 1.37 (1.13–1.67) 1.23 (1.01–1.50) 1.05 (1.03–1.08) <.001
Multivariate-adjusted OR
∗
(95% CI) 1.00 (Ref.) 1.05 (0.94–1.17) 1.11 (0.94–1.32) 1.25 (1.01–1.54) 1.04 (0.84–1.28) 1.03 (1.00–1.05) .055
CI= confidence interval, OR=odds ratio.
∗
Adjusted for age (continuous variable), sex (men and women combined only), alcohol consumption, education level, body mass index, physical activity (continuous variable), psychological stress, sleeping hours,
family history of hypertension in father, family history of hypertension in mother, medical history of diabetes mellitus, medical history of dyslipidemia, menstruation status (women only), and study area.
† The “4 to <6hours per day” and “≥6hours per day” categories were combined into one group because of the small number of men in the “≥6hours per day” group (n=55).
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The present study was conducted with a large national sample
and controlling for multiple potential confounders, adding to the
strengths of our study. One study limitation was that data on
exposure level to passive smoking were based on a self-
administered questionnaire; thus, misclassification might have
resulted from our evaluation of passive smoking. However, if
present, this would have been nondifferential and led to
underestimation of the associations. Some previous studies also
have demonstrated that self-reported exposure to passive
smoking among nonsmokers could be useful in epidemiological
studies,[42–44] and the self-administered questionnaire is the most
commonly used tool to ascertain exposure to passive smoking.[45]
In the present study, the positive association between passive
smoking andhypertensionwas stronger inmen than inwomen; the
reasons for this remainunclear.The difference in the strengthof the
association according to sex stems from the fact that the strength of
the exposure might differ by sex, even in the same response
category of exposure time to passive smoking, for reasons such as
occupation or other confounders.[44,46] We could not further
clarify this issue owing to the lack of occupation data. It might also
be necessary to consider the genetic background of participants
regarding blood pressure, as approximately 31% to 68%of blood
pressure variation could be genetically explained.[47] However,
genetic background appeared to be unrelated to exposure to
passive smoking because we observed no clear difference in family
history of hypertension between the exposure levels. Lastly, the
cross-sectional nature of the study does not permit us to draw
definite conclusions regarding the causal role of exposure to
passive smoking in hypertension among nonsmokers.
In conclusion, exposure to passive smoking was found to be
associated with the prevalence of hypertension in a large general
Japanese population, with a significant linear trend after
controlling for potential confounders. A government survey on
public health and nutrition in Japan, 2017, has reported that
7.4% of adults were exposed to passive smoking every day at
home and 30.1% of adults were exposed at least once a month in
offices.[48] As two-thirds of all deaths attributable to passive
smoking were caused by ischemic heart disease,[49] it is possible
that hypertension related to passive smoking contributes to the
death of ischemic heart disease due to passive smoking. Thus, a
total ban on smoking at public venues and further efforts to raise
public awareness about the dangers of passive smoking to
hypertension and related diseases would be important to reduce
the risk for these diseases. Our findings may add evidence to the
recommendation for greater restrictions on tobacco smoke in
public venues as well as at home or in offices, and emphasize the
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